Current concepts in secondary prevention after acute myocardial infarction. - Wikidata - awgldk - TriplyDB

Current concepts in secondary prevention after acute myocardial infarction.

Current concepts in secondary prevention after acute myocardial infarction.

http://www.wikidata.org/entity/Q33860933

about

Current concepts in secondary prevention after acute myocardial infarction.

http://www.wikidata.org/entity/Q33860933

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Current concepts in secondary prevention after acute myocardial infarction.

@ast

Current concepts in secondary prevention after acute myocardial infarction.

@en

type

label

Current concepts in secondary prevention after acute myocardial infarction.

@ast

Current concepts in secondary prevention after acute myocardial infarction.

@en

prefLabel

Current concepts in secondary prevention after acute myocardial infarction.

@ast

Current concepts in secondary prevention after acute myocardial infarction.

@en

P1433

Q33860933-464CF1E6-8376-4D82-ABFB-B2CC3F68BCA0

P1476

Q33860933-537E5BE4-B7EF-499E-A03A-4D49CAFD6EBC

P2093

Q33860933-2589FD5A-0B5E-456A-9457-5AC154C7C67C

Q33860933-3BDA71B6-6738-41DE-B341-6A2B487E1239

Q33860933-A582060D-B18C-4675-AF69-68824EF8D852

P2860

Q33860933-42012520-FC18-4BD4-A5E7-6F95C07FAE33

Q33860933-4CCBA745-F206-4032-B829-0D60EE4261B5

Q33860933-52BB93C7-C7D3-46A3-99B7-83D1D16DF953

Q33860933-6B5C0226-C32D-4C1D-8E4E-BC6C96D660C6

Q33860933-79B8A127-834B-405C-8E97-A59D6F12A44B

Q33860933-7B1F64AB-4A7E-4D9D-A4BF-9BE14E0EAC25

Q33860933-8753E685-D6A9-4385-8949-67B0014CEDA8

Q33860933-92B84560-8468-46F7-9BA6-66BA0F6D80FB

Q33860933-97988F25-B048-42C6-A70D-5945564B3DC2

Q33860933-9A6D08DD-8D5B-4CE0-8A50-20F77DAE642F

P304

Q33860933-C7AF9950-C3DF-43CF-AAD7-AEEDD7AE40BD

P31

Q33860933-459E3E6E-57F2-4511-AA2A-1781B60CED00

P356

Q33860933-71821064-EA41-4A5C-91D9-3755421D4975

P433

Q33860933-D43C2988-9D94-4193-9EF3-316437BBA5EE

P478

Q33860933-B18B709B-0C26-441C-A8D0-5C3D1137DB03

P577

Q33860933-0ED49789-E132-4D45-9232-AFEF19C0594A

P698

Q33860933-F2639CAA-C917-4CE6-A9A2-B2D42B9F67CD

P356

P1433

P1476

Current concepts in secondary prevention after acute myocardial infarction.

@en

P2093

Bossone E

http://www.w3.org/2001/XMLSchema#string

Eagle KA

http://www.w3.org/2001/XMLSchema#string

Mehta RH

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Secondary prevention in acute myocardial infarction.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

The use of beta-adrenergic blocking drugs in patients with myocardial infarction.

Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management.

Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

P304

47-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03044123

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10713909

http://www.w3.org/2001/XMLSchema#string